KOR
Investor Relations
REYON, Creating Value Together as a Sustainable Partner
Financial Information

Consolidated Statement of Financial Position

(unit: KRW 1 million)
Current assets
Non-current assets
Total assets
Current liabilities
Non-current liabilities
Total liabilities
Capital
Capital surplus
Other capital
Accumulated other comprehensive income
Retained earnings
Non-controlling interest
Total equity
Total equity and liabilities
Current assets
Non-current assets
Total assets
Current liabilities
Non-current liabilities
Total liabilities
Capital
Capital surplus
Other capital
Accumulated other comprehensive income
Retained earnings
Non-controlling interest
Total equity
Total equity and liabilities
Current assets
Non-current assets
Total assets
Current liabilities
Non-current liabilities
Total liabilities
Capital
Capital surplus
Other capital
Accumulated other comprehensive income
Retained earnings
Non-controlling interest
Total equity
Total equity and liabilities

Financial statement

(unit: KRW 1 million)
Current assets
Non-current assets
Total assets
Current liabilities
Non-current liabilities
Total liabilities
Capital
Capital surplus
Other capital
Accumulated other comprehensive income
Retained earnings
Total equity
Total equity and liabilities
Current assets
Non-current assets
Total assets
Current liabilities
Non-current liabilities
Total liabilities
Capital
Capital surplus
Other capital
Accumulated other comprehensive income
Retained earnings
Total equity
Total equity and liabilities
Current assets
Non-current assets
Total assets
Current liabilities
Non-current liabilities
Total liabilities
Capital
Capital surplus
Other capital
Accumulated other comprehensive income
Retained earnings
Total equity
Total equity and liabilities
12F, Building A, Mirae Asset Tower, 620 Teheran-ro, Gangnam-gu, Seoul, Korea
Copyright©REYON PHARMACEUTICAL CO., LTD.
All rights Reserved.